Hubungan Karakteristik Kanker Kolorektal dan Jenis Terapinya dengan Masa Survival Pasien di Rumah Sakit Umum Daerah Nganjuk

Muhammad Rizki Fitrianto, PratikaYuhyi Hernanda, Maria Widjianti Sugeng, Budiono Raharjo, Stephani Linggawan, Anton Sumarpo

Sari


ABSTRACT

 

Colorectal cancer survival refers to the prognosis of patients following a diagnosis of the disease. Various factors contribute to the survival outcomes of individuals diagnosed with colorectal cancer, including tumor characteristics—such as the tumor's location and stage—as well as the type of therapeutic interventions administered. This study aims to investigate the relationship between the characteristics of colorectal cancer, the therapeutic approaches employed, and patient survival rates at Nganjuk General Hospital. This study employed a retrospective design with a cross-sectional approach, focusing on patients diagnosed with colorectal cancer at Nganjuk General Hospital in Surabaya over the period from 2019 to 2024. The analysis of the associations among colorectal cancer metastasis, tumor location, and chemotherapy type with patient survival duration revealed the following p-values: 0.122 for the relationship between metastasis and survival period, 0.268 for the association between tumor location and survival, and 0.210 for the correlation between chemotherapy type and survival time. Our findings indicate that there is no significant association between the characteristics of colorectal cancer, the type of therapy administered, and the survival duration of patients treated at RSUD Nganjuk.

 

Keywords: Colorectal Cancer, Patient Survival, Therapeutic Intervention

 

 

ABSTRAK

 

Keberlangsungan hidup (survival) pada pasien dengan kanker kolorektal berkaitan erat dengan prognosis pasien dan waktu saat terdiagnosis (time-to-diagnosis). Berbagai faktor berkontribusi terhadap hasil kelangsungan hidup individu yang didiagnosis dengan kanker kolorektal, termasuk karakteristik tumor—seperti lokasi dan stadium tumor—serta jenis intervensi terapeutik yang diberikan. Penelitian ini bertujuan untuk menyelidiki hubungan antara karakteristik kanker kolorektal, pendekatan terapeutik yang digunakan, dan tingkat kelangsungan hidup pasien di Rumah Sakit Umum Daerah (RSUD) Nganjuk. Penelitian ini menggunakan desain retrospektif dengan pendekatan cross-sectional. Subjek penelitian yang digunakan adalah pasien yang didiagnosis dengan kanker kolorektal di RSUD Nganjuk di Surabaya selama periode 2019 hingga 2024. Hubungan antara metastasis kanker kolorektal, lokasi tumor, dan jenis kemoterapi terhadap durasi kelangsungan hidup pasien menunjukkan nilai p sebagai berikut: 0,122 untuk hubungan antara metastasis dan periode kelangsungan hidup, 0,268 untuk asosiasi antara lokasi tumor dan kelangsungan hidup, serta 0,210 untuk korelasi antara jenis kemoterapi dan waktu kelangsungan hidup. Penelitian kami menunjukkan bahwa tidak ada asosiasi yang signifikan antara karakteristik kanker kolorektal, jenis terapi yang diberikan, dan durasi kelangsungan hidup pasien yang dirawat di RSUD Nganjuk.

 

Kata Kunci: Kanker Kolorektal, Keberlangsungan Hidup, Intervensi Terapeutik


Teks Lengkap:

Download Artikel

Referensi


Adebayo, A. S., Agbaje, K., Adesina, S. K., & Olajubutu, O. (2023). Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives. Pharmaceutics, 15(11), 2620. https://doi.org/10.3390/pharmaceutics15112620

Allison, J. E., Tekawa, I. S., Ransom, L. J., & Adrain, A. L. (1996). A comparison of fecal occult-blood tests for colorectal-cancer screening. The New England Journal of Medicine, 334(3), 155–159. https://doi.org/10.1056/NEJM199601183340304

Babat, I., Polat, H., Umar Gursu, R., Bashan, Y., Kırık, A., Bektas, H., Sarı, S., & Usul Afşar, Ç. (2021). The effect of mutation status, pathological features and tumor location on prognosis ın patients with colorectal cancer. Revista Da Associacao Medica Brasileira (1992), 67(2), 185–189. https://doi.org/10.1590/1806-9282.67.02.20200321

Bai, X., Wei, H., Liu, W., Coker, O. O., Gou, H., Liu, C., Zhao, L., Li, C., Zhou, Y., Wang, G., Kang, W., Ng, E. K., & Yu, J. (2022). Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut, 71(12), 2439–2450. https://doi.org/10.1136/gutjnl-2021-325021

Bausys, A., Kryzauskas, M., Abeciunas, V., Degutyte, A. E., Bausys, R., Strupas, K., & Poskus, T. (2022). Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review. Cancers, 14(20), 5017. https://doi.org/10.3390/cancers14205017

Boyne, D. J., Cuthbert, C. A., O’Sullivan, D. E., Sajobi, T. T., Hilsden, R. J., Friedenreich, C. M., Cheung, W. Y., & Brenner, D. R. (2019). Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis. JAMA Network Open, 2(5), e194154. https://doi.org/10.1001/jamanetworkopen.2019.4154

Cai, Y., Jiang, L., Ju, H., Zhu, Y., & Liu, Z. (2024). Therapeutic strategies for ypT1 rectal cancer after neoadjuvant chemoradiotherapy: A retrospective cohort study. International Journal of Colorectal Disease, 39(1), 189. https://doi.org/10.1007/s00384-024-04764-y

Canadian Task Force on Preventive Health Care. (2016). Recommendations on screening for colorectal cancer in primary care. CMAJ, 188(5), 340–348. https://doi.org/10.1503/cmaj.151125

Chan, D. S. M., Lau, R., Aune, D., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011). Red and processed meat and colorectal cancer incidence: Meta-analysis of prospective studies. PloS One, 6(6), e20456. https://doi.org/10.1371/journal.pone.0020456

Costas-Chavarri, A., Nandakumar, G., Temin, S., Lopes, G., Cervantes, A., Cruz Correa, M., Engineer, R., Hamashima, C., Ho, G. F., Huitzil, F. D., Malekzadeh Moghani, M., Sharara, A. I., Stern, M. C., Teh, C., Vázquez Manjarrez, S. E., Verjee, A., Yantiss, R., & Shah, M. A. (2019). Treatment of Patients with Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline. Journal of Global Oncology, 5, 1–19. https://doi.org/10.1200/JGO.18.00214

Damato, A., Ghidini, M., Dottorini, L., Tomasello, G., Iaculli, A., Ghidini, A., Luciani, A., & Petrelli, F. (2023). Chemotherapy Duration for Various Indications in Colorectal Cancer: A Review. Current Oncology Reports, 25(4), 341–352. https://doi.org/10.1007/s11912-023-01378-5

de Kanter, C., Dhaliwal, S., & Hawks, M. (2022). Colorectal Cancer Screening: Updated Guidelines from the American College of Gastroenterology. American Family Physician, 105(3), 327–329.

Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019). Colorectal cancer. Lancet (London, England), 394(10207), 1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0

Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer, 149(4), 778–789. https://doi.org/10.1002/ijc.33588

Gill, S., Thomas, R. R., & Goldberg, R. M. (2003). Review article: Colorectal cancer chemotherapy. Alimentary Pharmacology & Therapeutics, 18(7), 683–692. https://doi.org/10.1046/j.1365-2036.2003.01735.x

Goyle, S., & Maraveyas, A. (2005). Chemotherapy for colorectal cancer. Digestive Surgery, 22(6), 401–414. https://doi.org/10.1159/000091441

Gustavsson, B., Carlsson, G., Machover, D., Petrelli, N., Roth, A., Schmoll, H.-J., Tveit, K.-M., & Gibson, F. (2015). A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clinical Colorectal Cancer, 14(1), 1–10. https://doi.org/10.1016/j.clcc.2014.11.002

Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019). The multiple mechanisms that regulate p53 activity and cell fate. Nature Reviews Molecular Cell Biology, 20(4), Article 4. https://doi.org/10.1038/s41580-019-0110-x

Johnson, D., Chee, C. E., Wong, W., Lam, R. C. T., Tan, I. B. H., & Ma, B. B. Y. (2024). Current advances in targeted therapy for metastatic colorectal cancer—Clinical translation and future directions. Cancer Treatment Reviews, 125, 102700. https://doi.org/10.1016/j.ctrv.2024.102700

Keum, N., & Giovannucci, E. (2019). Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology, 16(12), Article 12. https://doi.org/10.1038/s41575-019-0189-8

Khil, H., Kim, S. M., Hong, S., Gil, H. M., Cheon, E., Lee, D. H., Kim, Y. A., & Keum, N. (2021). Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea. Scientific Reports, 11, 2413. https://doi.org/10.1038/s41598-021-81877-2

Kumar, A., Gautam, V., Sandhu, A., Rawat, K., Sharma, A., & Saha, L. (2023). Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World Journal of Gastrointestinal Surgery, 15(4), 495–519. https://doi.org/10.4240/wjgs.v15.i4.495

Manzi, J., Hoff, C. O., Ferreira, R., Pimentel, A., Datta, J., Livingstone, A. S., Vianna, R., & Abreu, P. (2023). Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives. Cancers, 15(11), 3023. https://doi.org/10.3390/cancers15113023

Martinez-Bernabe, T., Pons, D. G., Oliver, J., & Sastre-Serra, J. (2024). Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer. Biomolecules, 14(11), 1359. https://doi.org/10.3390/biom14111359

Matsuda, T., Yamashita, K., Hasegawa, H., Oshikiri, T., Hosono, M., Higashino, N., Yamamoto, M., Matsuda, Y., Kanaji, S., Nakamura, T., Suzuki, S., Sumi, Y., & Kakeji, Y. (2018). Recent updates in the surgical treatment of colorectal cancer. Annals of Gastroenterological Surgery, 2(2), 129–136. https://doi.org/10.1002/ags3.12061

McQuade, R. M., Stojanovska, V., Bornstein, J. C., & Nurgali, K. (2017). Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches. Current Medicinal Chemistry, 24(15), 1537–1557. https://doi.org/10.2174/0929867324666170111152436

Ohishi, T., Kaneko, M. K., Yoshida, Y., Takashima, A., Kato, Y., & Kawada, M. (2023). Current Targeted Therapy for Metastatic Colorectal Cancer. International Journal of Molecular Sciences, 24(2), 1702. https://doi.org/10.3390/ijms24021702

Plummer, J. M., Leake, P.-A., Ferron-Boothe, D., Roberts, P. O., Mitchell, D. I., & McFarlane, M. E. (2016). Colorectal cancer survival in Jamaica. Annals of Medicine and Surgery, 6, 26–29. https://doi.org/10.1016/j.amsu.2016.01.018

Qian, B.-Z., & Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell, 141(1), 39–51. https://doi.org/10.1016/j.cell.2010.03.014

Rentsch, M., Schiergens, T., Khandoga, A., & Werner, J. (2016). Surgery for Colorectal Cancer—Trends, Developments, and Future Perspectives. Visceral Medicine, 32(3), 184–191. https://doi.org/10.1159/000446490

Shaukat, A., & Levin, T. R. (2022). Current and future colorectal cancer screening strategies. Nature Reviews Gastroenterology & Hepatology, 19(8), Article 8. https://doi.org/10.1038/s41575-022-00612-y

Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021). ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Official Journal of the American College of Gastroenterology | ACG, 116(3), 458. https://doi.org/10.14309/ajg.0000000000001122

Tantyo, N. A., Karyadi, A. S., Rasman, S. Z., Salim, M. R. G., Devina, A., & Sumarpo, A. (2019). The prognostic value of S100A10 expression in cancer (Review). Oncology Letters, 17(2), 1417–1424. https://doi.org/10.3892/ol.2018.9751

Xiang, Z., Wang, Y., Ma, X., Song, S., He, Y., Zhou, J., Feng, L., Yang, S., Wu, Y., Yu, B., Xia, G., Xu, W., Zhao, Y., & Wang, L. (2024). Targeting the NOTCH2/ADAM10/TCF7L2 Axis-Mediated Transcriptional Regulation of Wnt Pathway Suppresses Tumor Growth and Enhances Chemosensitivity in Colorectal Cancer. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), e2405758. https://doi.org/10.1002/advs.202405758

Xie, X., Fan, C., Luo, B., Zhang, J., Jensen, L. D., Burman, J., Jönsson, C., Ljusberg, A., Larsson, P., Zhao, Z., & Sun, X.-F. (2023). APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy. Molecular Cancer Therapeutics, 22(8), 947–961. https://doi.org/10.1158/1535-7163.MCT-22-0275

Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020). Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy, 5(1), 22. https://doi.org/10.1038/s41392-020-0116-z

Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., Chen, Y., Chen, H., Hong, J., Zou, W., & Fang, J.-Y. (2017). Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170(3), 548-563.e16. https://doi.org/10.1016/j.cell.2017.07.008

Zhang, S., Wang, Q., Zhou, C., Chen, K., Chang, H., Xiao, W., & Gao, Y. (2019). Colorectal cancer, radiotherapy and gut microbiota. Chinese Journal of Cancer Research, 31(1), 212–222. https://doi.org/10.21147/j.issn.1000-9604.2019.01.16




DOI: https://doi.org/10.33024/mahesa.v5i6.18564

Refbacks

  • Saat ini tidak ada refbacks.


Publisher: Universitas Malahayati Lampung

Creative Commons License
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License


kostenlose besucherzähler